Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population-based studies - PubMed (original) (raw)
Meta-Analysis
doi: 10.1111/apt.16372. Epub 2021 May 13.
Nicholas Powell 3, Marjorie M Walker 1 2, Mike P Jones 2 4, Jukka Ronkainen 5 6, Anna Forsberg 7, Lars Kjellström 8, Per M Hellström 9, Pertti Aro 10, Bengt Wallner 11, Lars Agréus 12, Anna Andreasson 4 7 13
Affiliations
- PMID: 33983640
- DOI: 10.1111/apt.16372
Meta-Analysis
Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population-based studies
Nicholas J Talley et al. Aliment Pharmacol Ther. 2021 Jul.
Abstract
Background: It is uncertain if functional dyspepsia (FD) or irritable bowel syndrome (IBS) are linked to smoking, and smoking cessation is not part of the routine advice provided to these patients.
Aim: To assess if smoking is an independent risk factor for FD and IBS.
Methods: Three population-based endoscopy studies in Sweden with 2560 community individuals in total (mean age 51.5 years, 46% male). IBS (14.9%), FD (33.5%), and associated symptoms were assessed using the validated abdominal symptom questionnaire, and smoking (17.9%) was obtained from standardised questions during a clinic visit. The effect of smoking on symptom status was analysed in an individual person data meta-analysis using mixed effect logistic regression, adjusted for snuffing, age and sex.
Results: Individuals smoking cigarettes reported significantly higher odds of postprandial distress syndrome (FD-PDS) (OR 10-19 cig/day = 1.42, 95% CI 1.04-1.98 P = 0.027, OR ≥20 cig/day = 2.16, 95% CI 1.38-3.38, P = 0.001) but not epigastric pain. Individuals smoking 20 or more cigarettes per day reported significantly higher odds of IBS-diarrhoea (OR = 2.40, 95% CI 1.12-5.16, P = 0.025), diarrhoea (OR = 2.01, 95%CI 1.28-3.16, P = 0.003), urgency (OR = 2.21, 95%CI 1.41-3.47, P = 0.001) and flatus (OR = 1.77, 95%CI 1.14-2.76, P = 0.012) than non-smokers. Smoking was not associated with IBS-constipation or IBS-mixed.
Conclusion: Smoking is an important environmental risk factor for postprandial distress syndrome, the most common FD subgroup, with over a twofold increased odds of PDS in heavy smokers. The role of smoking in IBS-diarrhoea, but not constipation, is also likely important.
© 2021 John Wiley & Sons Ltd.
Comment in
- Editorial: tobacco use in functional dyspepsia-another smoking gun?
Woo MMK, Andrews CN. Woo MMK, et al. Aliment Pharmacol Ther. 2021 Jul;54(1):78. doi: 10.1111/apt.16394. Aliment Pharmacol Ther. 2021. PMID: 34109667 No abstract available. - Editorial: tobacco use in functional dyspepsia-another smoking gun? Authors' reply.
Talley NJ, Walker MM, Agreus L, Andreasson A. Talley NJ, et al. Aliment Pharmacol Ther. 2021 Jul;54(1):79. doi: 10.1111/apt.16401. Aliment Pharmacol Ther. 2021. PMID: 34109668 No abstract available.
Similar articles
- Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh.
Perveen I, Rahman MM, Saha M, Rahman MM, Hasan MQ. Perveen I, et al. Indian J Gastroenterol. 2014 May;33(3):265-73. doi: 10.1007/s12664-014-0447-1. Epub 2014 Mar 26. Indian J Gastroenterol. 2014. PMID: 24664445 - Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
Choi YJ, Kim N, Yoon H, Shin CM, Park YS, Kim JW, Kim YS, Lee DH, Jung HC. Choi YJ, et al. J Gastroenterol Hepatol. 2017 Sep;32(9):1553-1561. doi: 10.1111/jgh.13756. J Gastroenterol Hepatol. 2017. PMID: 28160607 - Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome.
Fujiwara Y, Kubo M, Kohata Y, Machida H, Okazaki H, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Arakawa T. Fujiwara Y, et al. Intern Med. 2011;50(21):2443-7. doi: 10.2169/internalmedicine.50.6012. Epub 2011 Nov 1. Intern Med. 2011. PMID: 22041340 - Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome.
Marasco G, Maida M, Cremon C, Barbaro MR, Stanghellini V, Barbara G. Marasco G, et al. Aliment Pharmacol Ther. 2023 Jul;58(1):6-15. doi: 10.1111/apt.17513. Epub 2023 Apr 10. Aliment Pharmacol Ther. 2023. PMID: 37038318 Review. - Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia.
Ford AC, Marwaha A, Lim A, Moayyedi P. Ford AC, et al. Clin Gastroenterol Hepatol. 2010 May;8(5):401-9. doi: 10.1016/j.cgh.2009.07.020. Epub 2009 Jul 23. Clin Gastroenterol Hepatol. 2010. PMID: 19631762 Review.
Cited by
- Beyond Eosinophilic Esophagitis: Eosinophils in Gastrointestinal Disease-New Insights, "New" Diseases.
Talley NJ, Burns GL, Hoedt EC, Duncanson K, Keely S. Talley NJ, et al. J Can Assoc Gastroenterol. 2023 Nov 24;6(6):199-211. doi: 10.1093/jcag/gwad046. eCollection 2023 Dec. J Can Assoc Gastroenterol. 2023. PMID: 38106480 Free PMC article. Review. - Associations of modifiable factors with risk of irritable bowel syndrome.
Chen Y, Yang H, Song J, Chen W, Liu K, Liu B, Luo P, Sun X, He Z, Mao Y, Ye D. Chen Y, et al. Front Nutr. 2024 Jul 1;11:1362615. doi: 10.3389/fnut.2024.1362615. eCollection 2024. Front Nutr. 2024. PMID: 39010855 Free PMC article. - The prevalence and risk factors of irritable bowel syndrome (PRIBS study) among adults in low- and middle-income countries: A multicenter cross-sectional study.
Arnaout AY, Nerabani Y, Douba Z, Kassem LH, Arnaout K, Shabouk MB, Zayat H, Mayo W, Bezo Y, Arnaout I, Yousef A, Zeina MB, Aljarad Z; PRIBS Study Team. Arnaout AY, et al. Health Sci Rep. 2023 Oct 4;6(10):e1592. doi: 10.1002/hsr2.1592. eCollection 2023 Oct. Health Sci Rep. 2023. PMID: 37808932 Free PMC article. - British Society of Gastroenterology guidelines on the management of functional dyspepsia.
Black CJ, Paine PA, Agrawal A, Aziz I, Eugenicos MP, Houghton LA, Hungin P, Overshott R, Vasant DH, Rudd S, Winning RC, Corsetti M, Ford AC. Black CJ, et al. Gut. 2022 Sep;71(9):1697-1723. doi: 10.1136/gutjnl-2022-327737. Epub 2022 Jul 7. Gut. 2022. PMID: 35798375 Free PMC article. - The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study.
Xie N, Xie J, Wang Z, Shu Q, Shi H, Wang J, Liu N, Xu F, Wu J. Xie N, et al. Nutrients. 2022 Dec 1;14(23):5109. doi: 10.3390/nu14235109. Nutrients. 2022. PMID: 36501135 Free PMC article.
References
REFERENCES
- Talley NJ. What causes functional gastrointestinal disorders? A proposed disease model. Am J Gastroenterol. 2020;115:41-48.
- Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med. 2015;373:1853-1863.
- Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017;376:2566-2578.
- Mearin F, Pérez-Oliveras M, Perelló A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology. 2005;129:98-104.
- Koloski NA, Jones M, Weltman M, et al. Identification of early environmental risk factors for irritable bowel syndrome and dyspepsia. Neurogastroenterol Motil. 2015;27:1317-1325.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous